Tiliroside protects against diabetic nephropathy in streptozotocin-induced diabetes rats by attenuating oxidative stress and inflammation

doi:10.4239/wjd.v15.i11.2220

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (895)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-11) series, Tables (1-2) series.

Item

Count

PDF

HTML

483

Figures (1-11)

108

Tables (1-2)

121

Sum=739

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=122

Nov 15, 2024 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Nov 15, 2024; 15(11): 2220-2236
Published online Nov 15, 2024. doi: 10.4239/wjd.v15.i11.2220

Full Size Figure Download Figure

Figure 9 Effect of Tiliroside on renal fibrotic markers in experimental rats. A: Fibronectin; B: Transforming growth factor-beta 1. All results were statistically assessed by one-way ANOVA and Tukey’s post hoc test. ^aP < 0.05 vs Control; ^bP < 0.01 vs STZ. GB: Glibenclamide; TIL: Tiliroside; STZ: Streptozotocin; FN: Fibronectin; TGF-β1: Transforming growth factor-beta 1.

Citation: Shang Y, Yan CY, Li H, Liu N, Zhang HF. Tiliroside protects against diabetic nephropathy in streptozotocin-induced diabetes rats by attenuating oxidative stress and inflammation. World J Diabetes 2024; 15(11): 2220-2236
URL: https://www.wjgnet.com/1948-9358/full/v15/i11/2220.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i11.2220